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Translation initiation in protein synthesis regulated by eukaryotic initiation factors (eIFs) is
a crucial step in controlling gene expression. eIF3a has been shown to regulate protein
synthesis and cellular response to treatments by anticancer agents including cisplatin
by regulating nucleotide excision repair. In this study, we tested the hypothesis that
eIF3a regulates the synthesis of proteins important for the repair of double-strand DNA
breaks induced by ionizing radiation (IR). We found that eIF3a upregulation sensitized
cellular response to IR while its downregulation caused resistance to IR. eIF3a increases
IR-induced DNA damages and decreases non-homologous end joining (NHEJ) activity
by suppressing the synthesis of NHEJ repair proteins. Furthermore, analysis of existing
patient database shows that eIF3a expression associates with better overall survival
of breast, gastric, lung, and ovarian cancer patients. These findings together suggest
that eIF3a plays an important role in cellular response to DNA-damaging treatments by
regulating the synthesis of DNA repair proteins and, thus, eIIF3a likely contributes to the
outcome of cancer patients treated with DNA-damaging strategies including IR.
Keywords: eukaryotic initiation factor 3a (eIF3a), DNA repair, radiation, resistance, mRNA translation, protein
synthesis, gamma-H2A histone family member X (γ-H2AX)
INTRODUCTION
Eukaryotic initiation factors (eIFs) are a family of proteins that play important roles in mRNA
translation and protein synthesis. Recent growing evidence suggests that eIFs do not just participate
in translation initiation of global mRNAs but may also regulate synthesis of a subset of proteins
(Dong and Zhang, 2006; Dong et al., 2009). These regulatory functions have been thought to
contribute to the potential oncogenic role of eIFs (Hershey, 2015). Indeed, many eIFs were found
to have higher expression in human tumors and shown to have oncogenic activity (Yin et al.,
2011a). One of these eIFs, eIF3a, has been found to overexpress in many human cancers including
cancers of the breast (Bachmann et al., 1997), cervix (Dellas et al., 1998), esophagus (Chen and
Burger, 1999), stomach (Chen and Burger, 2004), lung (Pincheira et al., 2001), and bladder (Spilka
et al., 2014), and it was thought to be a proto-oncogene. Indeed, knocking down eIF3a expression
reversed the malignant phenotype of human cancer cells (Dong et al., 2004) while overexpressing
ectopic eIF3a transformed NIH3T3 fibroblast cells (Zhang et al., 2007) in vitro.
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Interestingly, eIF3a overexpression resulted in cellular
sensitivity to cisplatin by regulating nucleotide excision repair
(NER) via suppressing the synthesis of NER proteins (Liu et al.,
2011). It has also been shown that eIF3a upregulation increases
cellular sensitivity to anticancer drug doxorubicin, which inhibits
topoisomerase II and causes DNA double-strand breaks (DSBs;
Yin et al., 2011b). Extensive DSBs induced by various exogenous
and endogenous factors are one of the most fatal forms of DNA
damages (Helleday et al., 2007; Reynolds et al., 2012) and are used
for treating human cancers in the form of chemo and radiation
therapy. However, cancer cells with efficient repair of DSBs are
able to survive these treatments that cause DSBs using two major
mechanisms of repair of DSBs, homologous recombination (HR)
and non-homologous end joining (NHEJ; Hartlerode and Scully,
2009; Pardo et al., 2009). While HR repairs the damages using
undamaged and symmetrical chromosome as a template during
the S or G phase of the cell cycle (Helleday et al., 2007; Branzei
and Foiani, 2008), NHEJ repairs DSBs throughout all cell cycle
phases and is the major pathway in repairing ionizing radiation
(IR)-induced DSBs (van Gent et al., 2001; Rothkamm et al., 2003;
Lieber, 2010). The major proteins important in NHEJ repair
of DSBs include Ku (Ku70, Ku80) and DNA-PKcs to form the
DNA-PK enzyme (Gottlieb and Jackson, 1993; Yaneva et al.,
1997; Mari et al., 2006; Uematsu et al., 2007).
In this study, we tested the hypothesis that eIF3a may regulate
the cellular response to treatments that cause DSBs by regulating
the synthesis of DSB repair proteins. We examined the role of
eIF3a in the cellular response to IR because IR is a common
and an important strategy for treating many types of human
cancers (Hoeijmakers, 2001; Kastan and Bartek, 2004; Lobrich
and Jeggo, 2007) and is known to cause DSBs. We found
that eIF3a sensitized the cellular response to IR treatments by
downregulating NHEJ repair via inhibiting the synthesis of NHEJ
repair proteins including Ku70, Ku80, and DNA-PKcs. These
findings suggest that translational regulation of gene expression
and eIF3a play important roles in the cellular response to DNA-
damaging treatments and, thus, may underline the molecular
basis of their functions in cellular response to drug/radiation-
induced DNA damages and in cancer prognosis.
RESULTS
Role of Eukaryotic Initiation Factor 3a in
the Cellular Response to Ionizing
Radiation Treatment
To determine the potential role of eIF3a in the cellular response
to IR, we first knocked down eIF3a expression using siRNA
in H1299 cells, which have a high level of endogenous eIF3a
(Figure 1A) followed by analysis of cellular response to IR
using colony formation assay. As shown in Figures 1B,C, H1299
cells with eIF3a knockdown (H1299/Si) are significantly more
resistant with a 2-fold increase in relative resistance factor
(RRF) than the control H1299 cells transfected with scrambled
control siRNA (H1299/Scr). To confirm this observaiton, we
performed a reverse experiment by using the stable NIH3T3
cells with eIF3a overexpression (NIH3T3/eIF3a) (Figure 1A) and
tested their response to IR in comparison with the control cells
transfected with the empty vector (NIH3T3/Vec). As shown in
Figures 1B,C, NIH3T3/eIF3a cells are remarkably more sensitive
than the control NIH3T3/Vec cells to IR with ∼2-fold reduction
in RRF. Thus, eIF3a expression may affect cellular sensitivity
to IR treatments.
Effect of Eukaryotic Initiation Factor 3a
on Gamma-H2A Histone Family Member
X Expression Following Ionizing
Radiation Treatment
To investigate how eIF3a affects the cellular response to IR,
we tested the hypothesis that eIF3a may regulate the repair of
DSBs induced by IR. For this purpose, we first tested the effect
of eIF3a on gamma-H2A histone family member X (γ-H2AX)
expression, a marker for DSB (Kuo and Yang, 2008), following IR
treatment. As shown in Figure 2A, little γ-H2AX was detected
in either H1299/Si or the control H1299/Scr cells without IR
treatments. However, the γ-H2AX level drastically increased
following IR treatment in these cells at 20 min after IR treatment.
Interestingly, at 6 h after IR, γ-H2AX in H1299/Si cells returned
essentially to the basal level while it remained high in the control
H1299/Scr cells. We also performed similar experiments using
NIH3T3/eIF3a and the control NIH3T3/Vec cells and found that
eIF3a overexpression clearly delayed DNA repair, as indicated by
the delayed disappearance of γ-H2AX (Figure 2A), consistent
with the findings using H1299/Si and H1299/Scr cells.
To verify the above findings, we performed
immunofluorescence staining of γ-H2AX in the nuclei of
these cells at 2 and 6 h after IR exposure. As shown in Figure 2B,
the high level of punctate staining of γ-H2AX in the nuclei of
H1299/Si cells observed at 2 h following IR disappeared at 6 h.
However, the punctate staining in the control H1299/Scr cells
remained high at 6 h following IR. Similarly, NIH3T3/eIF3a
cells retained high levels of γ-H2AX, whereas the control
NIH3T3/Vec cells lost γ-H2AX staining at 6 h following IR.
These observations are consistent with the results shown using
Western blot analysis. Thus, it is possible that eIF3a suppresses
the repair of DSB induced by IR.
Effect of Eukaryotic Initiation Factor 3a
on DNA Damage Induced by Ionizing
Radiation
In the above studies, we used γ-H2AX as a DNA damage marker
to evaluate DNA damage and repair. To directly evaluate DNA
damage induced by IR in the presence of different levels of eIF3a,
we performed neutral comet assay at 2 and 6 h following IR
treatment. Cells at 20 min following IR were not tested using
this assay because the short time was difficult to control for
the comet assay. As shown in Figure 3A, H1299/Si cells clearly
have significantly lower Olive tail moment than the control
H1299/Scr cells at both 2 and 6 h following IR treatment. It
is noteworthy that the relative Olive tail moment was reduced
at 6 h compared with 2 h following IR in H1299/Si cells while
it remained high in H1299/Scr cells, suggesting that little DSBs
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FIGURE 1 | Effect of eukaryotic initiation factor (eIF)3a expression on the cellular response to ionizing radiation (IR). Western blot analyses (A) and colony formation
assay following IR treatment (B) of H1299 cells with transient eIF3a knockdown and NIH3T3 cells with stable eIF3a overexpression compared with their respective
control cells. Actin was used as a loading control. Panel (C) shows a summary of eIF3a effects on cellular sensitivity to IR treatments. Relative resistance factor (RRF)
was derived by dividing the IC50 of the test cells by that of their control cells (n = 3, **P < 0.01).
were repaired in H1299/Scr cells compared with H1299/Si cells.
Similarly, NIH3T3/eIF3a cells had significantly higher Olive tail
moment than its control NIH3T3/Vec cells (Figure 3B) following
IR treatment, and less DSBs were repaired in NIH3T3/eIF3a
than in the control NIH3T3/Vec cells as indicated by the
change in the relative Olive tail moment between 2 and 6 h
following IR. Thus, eIF3a likely inhibits the repair of DSBs
induced by IR, and cells with high levels of eIF3a retain higher
levels of DSBs following IR while cells with lower eIF3a retain
lower level of DSBs.
Role of Eukaryotic Initiation Factor 3a in
Non-homologous End Joining Repair of
Double-Strand Breaks
To determine if eIF3a regulates repairs of DSBs, we next
performed host cell reactivation (HCR) assay of NHEJ activity
since NHEJ is the main repair pathway of IR-induced DNA
damages and it is independent of cell cycle stages as discused
above. As shown in Figure 3C, H1299/Si cells had a 2-fold
increase in NHEJ activity compared with the control H1299/Scr
cells. Consistently, the NHEJ activity in NIH3T3/eIF3a cells was
decreased by 40% compared with the control NIH3T3/Vec cells
(Figure 3D). These findings suggest that eIF3a may play an
important role in suppressing NHEJ repair of DSBs.
Eukaryotic Initiation Factor 3a Regulates
Synthesis of Non-homologous End
Joining Repair Proteins
Because eIF3a is known to regulate the synthesis of proteins,
we hypothesized that eIF3a may regulate NHEJ repair of DSBs
by regulating the synthesis of NHEJ repair proteins. To test
this hypothesis, we first performed a Western blot analysis
of major proteins involved in NHEJ repair in H1299/Si vs.
H1299/Scr and NIH3T3/eIF3a vs. NIH3T3/Vec cells. As shown
in Figures 4A,B, the expression of DNA-PKcs, Ku70, and Ku80
in H1299/Si cells was drastically increased compared with the
control H1299/Scr cells. Consistently, the expression of these
genes in NIH3T3/eIF3a cells was dramatically reduced compared
with the control NIH3T3/Vec cells. Interestingly, real-time
reverse transcription (RT)-PCR analyses showed no change in
the mRNA level of these genes, suggesting that the effect of eIF3a
on the expression of DNA-PKcs, Ku70, and Ku80 is likely at the
protein, not mRNA, level.
Next, we performed pulse labeling and cycloheximide chase
experiments to determine the eIF3a effect on the synthesis and
degradation of these DNA repair proteins, respectively. As shown
in Figure 5, eIF3a knockdown using siRNA in H1299 cells
(Figure 5A) or eIF3a overexpression in NIH3T3 cells (Figure 5B)
had no effects on the decay of these DNA repair proteins.
However, the synthesis of Ku70, Ku80, and DNA-PKcs was
dramatically increased in H1299/Si (Figure 5A) and reduced in
NIH3T3/eIF3a (Figure 5B) cells compared with their respective
control H1299/Scr and NIH3T3/Vec cells. Thus, eIF3a likely
inhibits the synthesis of Ku70, Ku80, and DNA-PKcs proteins,
leading to a reduced repair of DSB by the NHEJ pathway.
High Eukaryotic Initiation Factor 3a
Expression Benefits Overall Survival of
Cancer Patients
The above studies suggest that patients with tumors that have a
high level of eIF3a may be more sensitive to treatments that cause
DSBs such as radiotherapy and chemotherapy with drugs that
cause DSBs. To test this hypothesis, we performed overall survival
analysis of breast, gastric, lung, and ovarian cancer patients using
information freely available in Kaplan–Meier (KM) plotter. As
shown in Figure 6, breast, gastric, lung, and ovarian cancer
patients with a high eIF3a expression level all had better overall
survival than patients with a low eIF3a level. These findings are
consistent with the eIF3a function in sensitizing cancer cells to
treatment that cause DNA damages.
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FIGURE 2 | Effect of eukaryotic initiation factor (eIF)3a on ionizing radiation (IR)-induced gamma-H2A histone family member X (γ-H2AX). Western blot (A) and
immunofluorescence staining (B) analyses of γ-H2AX in H1299 cells with transient eIF3a knockdown and in NIH3T3 cells with stable eIF3a overexpression
compared with their respective control cells following IR treatments.
FIGURE 3 | Role of eukaryotic initiation factor (eIF)3a in non-homologous end joining (NHEJ) repair of ionizing radiation (IR)-induced double-strand breaks (DSBs).
(A,B) Comet assay was used to determine eIF3a effects on the level of DSBs induced by IR in H1299 cells with transient eIF3a knockdown (A) and NIH3T3 cells
with stable eIF3a overexpression (B) compared with their respective control cells. The histograms show the summary of quantitative analysis of Olive tail moment in
these cells. (C,D) Host cell reactivation assays using reporter constructs were performed using H1299 cells with eIF3a knockdown (C) and NIH3T3 cells with eIF3a
stable overexpression (D) compared with their respective control cells (n = 3; **P < 0.01).
DISCUSSION
Appropriate combinations of radiation with chemotherapeutic
drugs and radiation have resulted in remarkable outcome
in cancer treatments. However, resistance to both radiation
and anticancer drugs frequently occurs, causing failure in the
successful treatment or cure of human cancers. In this study,
using cell line models, we show that eIF3a may play important
roles in the cellular response to IR with several lines of evidence.
Alteration of eIF3a expression not only changes cellular survival
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FIGURE 4 | Effect of eukaryotic initiation factor (eIF)3a on expression of genes encoding proteins important for non-homologous end joining (NHEJ) repair. Western
blot and real-time reverse transcription (RT)-PCR analyses were performed to determine the effect of eIF3a on the expression of Ku70, Ku80, and DNA-PKcs genes
in H1299 cells with transient knockdown (A) and NIH3T3 cells with stable eIF3a overexpression (B) compared with their respective control cells (n = 3; **P < 0.01).
following IR treatment, it also affects the levels of DSBs as
measured using the comet assay and detecting γ-H2AX, an
indicator of DNA damage as well as HCR assay for NHEJ
repair activities. Furthermore, eIF3a may regulate the synthesis
of DNA repair proteins, Ku70, Ku80, and DNA-PKcs, important
for the NHEJ repair pathway. These findings are consistent
with the observation that lower eIF3a expression associates with
poor prognosis of several cancers in this study and as reported
in previous publications (Bachmann et al., 1997; Dellas et al.,
1998; Chen and Burger, 1999, 2004; Pincheira et al., 2001;
Spilka et al., 2014).
The difference in γ-H2AX protein level between cells with
different eIF3a levels was observed early (20 min) following IR
treatments. Although eIF3a may sensitize cells from IR-induced
DNA damage to reduce the production of γ-H2AX, it is more
likely that cells with different eIF3a levels have similar levels of
DSBs induced by IR, but the cells with less eIF3a can repair
the DSBs much more quickly than the cells with a high eIF3a
level, causing the different levels of γ-H2AX in these cells. This
difference in repair activity may be due to the difference in the
basal level of DNA repair proteins between these cells under
different levels of eIF3a regulation. It is noteworthy that DNA-
PKcs, the downstream target of eIF3a shown here, has been
suggested to phosphorylate H2AX, leading to the production of
IR-induced γ-H2AX (Stiff et al., 2004). In this study, although
eIF3a knockdown increased the level of DNA-PKcs protein,
there is no increase in the basal level of γ-H2AX. In fact,
γ-H2AX decreased in eIF3a knockdown cells at 20 min following
IR treatment. While this finding is consistent with less DNA
damage in eIF3a knockdown cells presumably due to increased
NHEJ repair activity, it is inconsistent with possible DNA-PKcs
phosphorylation of H2AX. However, because half maximum
accumulation of γ-H2AX occurs in 1 min following IR (Rogakou
et al., 1998), it is possible that we were unable to detect the
IR-induced γ-H2AX increase due to high DNA-PKcs expression
with eIF3a knockdown. At 20 min or later after IR when samples
were collected, γ-H2AX may have already been reduced due
to rapid reduction in DSBs. Future studies are required to test
this possibility.
Previously, it has been shown that eIF3a regulates the synthesis
of proteins important for NER and cellular response to cisplatin
and that eIF3a may bind to the 5′-untranslated region (5′-UTR)
of mRNAs encoding DNA repair proteins and, thus, inhibiting
translation of these mRNAs to synthesize these proteins (Liu
et al., 2011; Yin et al., 2011b, 2013). Together with these previous
findings, our current results suggest that eIF3a likely plays an
important role in regulating the synthesis of DNA repair proteins
that contributes to cellular response to DNA-damaging drugs
or radiation (Figure 7). In a previous study, we showed that
eIF3a knockdown sensitized cancer cells to cisplatin-induced
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FIGURE 5 | Effect of eukaryotic initiation factor (eIF)3a on the synthesis and degradation of Ku70, K80, and DNA-PKcs. Pulse labeling in combination with
immunoprecipitation and cycloheximide chasing were performed to determine the synthesis (insets) and degradation, respectively, of Ku70, Ku80, and DNA-PKcs in
H1299 cells with transient eIF3a knockdown (A) and NIH3T3 cells with stable eIF3a overexpression (B) compared with their respective control cells.
apoptosis (Liu et al., 2011), further supporting the conclusion that
eIF3a may contribute to cellular sensitivity to DNA-damaging
treatments by suppressing DNA repair and by increasing DNA
damage-induced apoptosis. We have also found in the previous
study (Liu et al., 2011) that a selected cisplatin-sensitive cell
line expressed a higher level of eIF3a compared with the parent
cell line, suggesting that cancer cells may alter eIF3a expression
to adapt to a DNA-damaging environment by regulating DNA
damage repair protein synthesis.
As discussed above, eIF3a may also have oncogenic functions
(Dong et al., 2004; Zhang et al., 2007). This oncogenic function
may relate to the finding that eIF3a suppresses DNA repair
via suppressing the synthesis of DNA repair proteins. Reduced
DNA damage repair activity due to eIF3a overexpression in
normal cells likely reduces the protection against DNA-damaging
carcinogens, leading to an increased possibility of carcinogenesis
(Figure 7). Further studies are required to test this theory.
The fact that eIF3a does not contribute to cellular response
to non-DNA-damaging drugs such as vinca alkaloid (Yin et al.,
2011b) suggests that eIF3a regulation of cellular response to
DNA-damaging treatments may be a specific event. Whether
eIF3a also regulates the synthesis of proteins important for other
DNA repair pathways such as HR for repair of DSBs remains
to be determined. Nevertheless, the findings that eIF3a may
suppress the synthesis of DNA repair proteins and contribute
to the increased sensitivity of cancer cells to DNA-damaging
treatments suggest that eIF3a may be developed as a biomarker
for precision medicine prescription. Patients with a high level
of eIF3a may benefit from DNA-damaging drug and radiation
treatment, whereas such treatments may not be as much of
a benefit for patients with a low level of eIF3a. Indeed, we
observed that patients with a high level of eIF3a expression have
significantly better overall survival than patients with a low eIF3a
level in breast, gastric, lung, and ovarian cancers. Future studies
are also warranted to investigate the possibility to target eIF3a
regulation of DNA repair protein synthesis to sensitize resistance
to DNA-damaging treatments.
In addition to the regulation in the synthesis of DNA repair
proteins, eIF3a has also been observed to possibly regulate
the synthesis of p27 and ribonucleotide reductase (Dong and
Zhang, 2003; Dong et al., 2004). The findings that eIF3a
suppresses the synthesis of DNA repair proteins are against
the intuition and belief that eIF3a facilitates translational
initiation as a subunit of eIF3 complex, and it would increase
protein synthesis in general. Because eIF3a is thought to be a
subunit of the eIF3 complex consisting of 13 putative subunits,
eIF3a regulation of synthesis of DNA repair proteins may be
indirect due to the effect of its upregulation or knockdown
on the formation of the complex or sub-complexes of other
eIF3 subunits. For example, it is noteworthy that eIF3e was
discovered as int-6, a site of mouse mammary tumor virus
(MMTV) integration (Asano et al., 1998), suggesting a tumor
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FIGURE 6 | Association of eukaryotic initiation factor (eIF)3a expression with overall survival of breast, gastric, lung, and ovarian cancers. Overall survival analyses
were conducted using Kaplan–Meier (KM) plotter with hazard ratio (HR) at 95% confidence intervals and log rank P < 0.05 considered significant.
suppressor function. While the role of eIF3e in translational
control is not yet established, the studies in yeast support
a tumor suppressor role in ameliorating oxidative damage
associated with nutritional stress conditions (Udagawa et al.,
2008; Nemoto et al., 2010). In mammals, the functional core of
eIF3 is defined with eIF3a, b, c, e, f, and h subunits (Masutani
et al., 2007), and eIF3a appears to be the docking site for
eIF3a:b:i:g sub-complex formation (Zhou et al., 2008; Dong
et al., 2013). In light of these previous findings, it is possible
that eIF3a knockdown or overexpression changes the spectrum
in forming eIF3 sub-complexes including other eIF3 subunits
such as eIF3e, which may mediate the regulation of DNA repair
protein synthesis.
As an alternative possibility, eIF3a may have an additional
regulatory non-canonical function not associated with the eIF3
complex or sub-complexes. The fact that eIF3a suppresses the
synthesis of some proteins (e.g., DNA repair proteins) while
increasing the synthesis of others (e.g., ribonucleotide reductase)
(Dong et al., 2004) and Chk1 (Dong et al., 2020) supports
this concept. How eIF3a regulates protein synthesis with its
non-canonical activity remains unknown. However, the previous
finding that eIF3a can bind to the 5′-UTRs of RPA2 mRNA
(Yin et al., 2013) suggests that eIF3a may bind to these mRNAs
and suppress the translation of these mRNAs. It also remains
to be determined whether this non-canonical activity requires
other eIF3 subunits such as eIF3b or eIF3i. Recently, eIF3i
has also been shown to be able to regulate the synthesis of
cyclooxygenase (COX)2 (Qi et al., 2014), suggesting that other
eIF3 subunits may also have non-canonical activity, although
it is not clear if they work together. Clearly, more studies are
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FIGURE 7 | Hypothetical model of eukaryotic initiation factor (eIF)3a regulation
of DNA repair protein synthesis relationship with DNA damage resistance and
tumorigenesis. Binding of eIF3a to 5′-untranslated regions (5′-UTRs) of
mRNAs encoding DNA damage repair proteins inhibits translation and
synthesis of DNA repair proteins, leading to sensitization of cancer cells to
DNA-damaging treatments and susceptibility of normal cells to
DNA-damaging carcinogens.
needed to investigate further the non-canonical function of eIF3
subunits vs. alteration of eIF3 complex/sub-complex formation
in regulating protein synthesis.
MATERIALS AND METHODS
Materials
Cell culture media and reagents were purchased from BioSources
International (Camarillo, CA), Media Tech (Herndon, CA), or
Cambrex (Walkersville, MD). All electrophoresis reagents and
polyvinylidene difluoride (PVDF) membranes were purchased
from Bio-Rad (Hercules, CA). SYBR Green PCR Master Mix
for real-time PCR, the high-capacity cDNA reverse transcription
kit, and all primers were purchased from Applied Biosystems-
Thermo Fisher (Chicago, IL). Metafectene R© pro was purchased
from Biontex (San Diego, CA). All other chemicals and reagents
were of molecular biology grade from Sigma (St. Louis, MO) or
Fisher Scientific (Chicago, IL).
Cell Culture and Survival Assay
Human lung cancer cell line H1299 and NIH3T3 cells were
cultured at 37◦C with 5% CO2 in RPMI 1640 and Dulbecco’s
modified Eagle’s medium (DMEM) medium, respectively,
supplemented with 10% fetal bovine serum, 100 units/ml
penicillin, and 100 µg/ml streptomycin. G418 at 400 µg/ml was
also supplemented in the culture of the stable NIH3T3 cells
overexpressing eIF3a and vector-transfected controls, which were
established in our previous study (Yin et al., 2011b).
Colony formation survival assay was performed following IR
treatments as previously described (Li et al., 2010; Wu et al.,
2016). Briefly, 100 cells/well were seeded in six-well plates and
cultured for 24 h followed by treatments with different doses of
IR and continuous culture for 10–14 days with media changed
every 2–3 days. At the end of the study, cells were washed with
phosphate-buffered saline (PBS), and the colonies were stained
with 0.05% (w/v) crystal violet in PBS containing 20% methanol
for 15 min at room temperature and counted manually.
Western Blot, Immunofluorescence
Staining, and Immunoprecipitation
Western blot analysis and immunofluorescence staining were
performed as previously described (Dong and Zhang, 2003;
Wu et al., 2016). Briefly, for Western blot analysis, equal
amount of proteins from different cells were separated by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE), transferred to PVDF membranes, and probed with
antibodies specific to eIF3a, γ-H2AX, Ku70, Ku80, DNA-
PKcs, and actin control followed by probing with horseradish
peroxidase (HRP)-conjugated secondary antibody and enhanced
chemiluminescence (ECL) reagents. The signals are captured on
X-ray films.
Immunofluorescence staining was performed by culturing
cells on glass coverslips, which were washed twice with cold PBS
and fixed with acetone/methanol mixture (1:1) for 10 min and
blocked in 1% bovine serum albumin (BSA) and 1% normal
horse serum in PBS at 4◦C for 30 min. The coverslips were
then probed with the γ-H2AX-specific antibody for 30 min
at 4◦C followed by incubation with fluorescein isothiocyanate
(FITC)-conjugated secondary antibody at room temperature for
30 min and washed twice with PBS. The cells were counterstained
with 4′,6-diamidino-2-phenylindole (DAPI) before viewing on a
confocal microscope.
Immunoprecipitation was performed as previously described
(Dong and Zhang, 2003). Briefly, cell lysates were first mixed
with mouse immunoglobulin G (IgG) and incubated for 2 h
at 4◦C followed by addition of 50% protein G-agarose slurry
and incubation for 3 h at 4◦C to remove non-specifically bound
proteins by centrifugation. The supernatant was transferred to a
new tube and incubated with 5 µg primary antibodies against
Ku70, Ku80, or DNA-PKcs at 4◦C for 2 h. Finally, 50 µl
50% protein G-agarose beads was added to the mixtures and
incubated at 4◦C overnight. The immunoprecipitated materials
were collected by centrifugation and extensive washing with lysis
buffer followed by separation using SDS-PAGE.
Real-Time Reverse Transcription-PCR
Real-time RT-PCR was performed as described previously (Dong
et al., 2004, 2005). Briefly, total RNA was extracted using RNeasy
Mini Kit (Qiagen, Valencia, CA), and real-time RT-PCR was
performed using Power SYBR Green RNA-to-CT 1-Step kit. Data
were normalized to an internal control gene, glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). The sequences of
primers for the PCRs were 5-CATGGCAACTCCAGAGCAG
(forward) and GCTCCTTAAACTCATCCACC (reverse)
for Ku70; AGAAGAAGGCCAGCTTTGAG (forward)
and AGCTGTGACAGAACTTCCAG (reverse) for
Ku80; CCGGACGGACCTACTACGACT (forward) and
AGAACGACCTGGGCATCCT (reverse) for DNA-PKcs.
Comet Assay
Neutral comet assay was performed as previously described
(Wu et al., 2016). Briefly, cells treated with or without IR
were embedded in low melting agarose on a microscope slide
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followed by lysis at neutral pH and electrophoresis in Tris-
borate-ethylenediaminetetraacetic acid (TBE) buffer for 2 h.
Comets were observed after staining the cells with SYBR
Green I and scoring 120 cells in each sample to measure the
Olive tail moment.
Host Cell Reactivation-Based
Non-homologous End Joining Assay
Host cell reactivation NHEJ assay was performed using
pGL3 reporter plasmid with firefly luciferase gene driven by
cytomegalovirus (CMV) promoter as previously described (Wu
et al., 2016). Briefly, pGL3 was first linearized byHindIII digestion
and co-transfected into cells along with the control circular
pRL-TK reporter plasmid encoding Renilla luciferase followed
by determination of both firefly and Renilla luciferase activity.
Expression of firefly luciferase is dependent on the repair of the
plasmid to regenerate the circular plasmid via NHEJ.
Protein Synthesis and Stability Assays
Pulse labeling using [35S]methionine in combination with
immunoprecipitation and SDS-PAGE analysis was used to
determine the protein synthesis rate as previously described
(Dong and Zhang, 2003; Dong et al., 2004). Briefly, cells
were washed with PBS and methionine-free media before
being subjected to labeling with [35S]methionine (10 µCi/ml)
in methionine-free media for 2 h. The cells were then
washed with PBS and harvested for cell lysate preparation,
immunoprecipitation, and separation by SDS-PAGE. The signals
for immunoprecipitated proteins labeled by [35S]methionine
were captured by exposing to X-ray films.
The stability of specific proteins was determined using
cycloheximide chasing as previously described (Liu et al., 2006).
Briefly, cells were treated with 10 µg/ml cycloheximide for
different times and harvested for preparation of cell lysates
and Western blot analyses. The quantity of each protein at
each time point of cycloheximide treatment was determined
using the ImageJ software (NIH, USA) and plotted against
the treatment time.
Overall Survival Analyses
The KM plotter can assess the effect of 54,675 genes on survival
using 10,461 cancer samples, including 5,143 breast, 1,816
ovarian, 2,437 lung, and 1,065 gastric cancer patients with a
mean follow-up of 69/40/49/33 months (Lanczky et al., 2016).
The analyses on all four cancers were conducted using default
parameters, and the hazard ratio (HR) with 95% confidence
intervals and log rank P < 0.05 considered significant were
calculated and shown on the plot.
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